Source: Annual Congress 2004 - Sarcoidosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. S. Tolokh (Lviv, Ukraine). Neoplastic markers in pulmonary sarcoidosis. Eur Respir J 2004; 24: Suppl. 48, 4367

Member's Comments

No comment yet.

Related content which might interest you: Cellular infiltrates of the bronchus in pulmonary sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 486s Year: 2003 Pulmonary sarcoidosis Source: Eur Respir Monogr 2022; 96: 122-141 Year: 2022 Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease Source: International Congress 2014 – Sarcoidosis Year: 2014 Pulmonary and pleural manifestations in scleroderma Source: Eur Respir J 2006; 28: Suppl. 50, 382s Year: 2006 Pathogenesis of pulmonary fibrosis in sarcoidosis Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020 Renal involvement in chronic pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 550s Year: 2005 Diffuse dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: A distinct entity or a variant of idiopathic pulmonary fibrosis? Source: International Congress 2014 – ILDs 1 Year: 2014 Pulmonary and extrapulmonary sarcoidosis immunophenotyping study Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009 Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Interstitial lung abnormalities with a diagnosis of idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Immunophenotypic profiles of lung carcinomas associated with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Inflammatory markers can predict pulmonary exacerbations of cystic fibrosis Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers Year: 2017 VEGF expression does not differentiate between idiopathic pulmonary fibrosis and pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 Histogenesis of pulmonary lymphangioleiomyomatosis Source: Eur Respir J 2003; 22: Suppl. 45, 74s Year: 2003 Significance of histopathologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis Source: International Congress 2015 – Connective tissue disorders Year: 2015 Comparison of physiological impairment in ILD patients with and without diagnostic IPF features Source: International Congress 2014 – ILDs 4 Year: 2014 Comparison between patients with idiopathic pulmonary fibrosis and patients with pulmonary involvement of the usual interstitial pneumonia pattern that preceded the onset of rheumatoid arthritis Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Pulmonary hypertension in orphan lung diseases Source: Eur Respir Mon 2011; 54: 317-331 Year: 2011 Pulmonary hypertension associated with sarcoidosis Source: Eur Respir Mon 2012; 57: 166-181 Year: 2012